Conference Coverage
Conference Coverage
Older age doesn’t decrease HRQOL among PBSC donors
Photo courtesy of Canterbury District Health Board SAN DIEGO—New research indicates that older stem cell donors have somewhat poorer overall...
Conference Coverage
Ibrutinib demonstrates efficacy in CLL after allo-HSCT
Photo courtesy of CDC SAN DIEGO—Ibrutinib can produce favorable results in heavily pretreated patients with chronic lymphocytic leukemia (CLL)...
Conference Coverage
Teamwork key to head and neck cancer management
Conference Coverage
Predicting outcomes of allo-HSCT in ALL
Photo by Chad McNeeley SAN DIEGO—A retrospective study has revealed a few factors that may predict outcomes of allogeneic hematopoietic stem cell...
Conference Coverage
Product ‘solves engraftment problem’ with UCBT
Photo courtesy of NHS SAN DIEGO—A product that promotes CD34 expansion has solved the problem of poor engraftment associated with umbilical cord...
Conference Coverage
Expanded MSCs can treat severe aGVHD
SAN DIEGO—Infusions of expanded mesenchymal stem cells (MSCs) can treat severe, steroid-resistant, acute graft-vs-host disease (aGVHD) in...
Conference Coverage
Day 90 CR not a good endpoint for auto-HSCT, doc says
Photo by Rhoda Baer SAN DIGEO—A phase 3 study comparing conditioning regimens in multiple myeloma patients undergoing autologous transplant...
Conference Coverage
Jury still out on survival benefit of resecting primary in mCRC
Key clinical point: Data are mixed regarding an overall survival benefit of resecting the primary tumor. Major finding: Two studies found a...
Conference Coverage
Ro-CHOP: Toxicity increases with efficacy
Photo by Larry Young SAN FRANCISCO—Adding romidepsin to CHOP can enhance the regimen’s efficacy against peripheral T-cell lymphoma (PTCL), but...
Conference Coverage
Mogamulizumab in PTCL: Europe vs Japan
Photo by Larry Young SAN FRANCISCO—Two phase 2 studies testing mogamulizumab in peripheral T-cell lymphomas (PTCLs) suggest that higher response...
Conference Coverage
MicroRNA may be therapeutic target for ALK- ALCL
Photo by Larry Young SAN FRANCISCO—MicroRNA-155 (miR-155) can act as an oncogenic driver in ALK− anaplastic large-cell lymphoma (ALCL) and may...